Elsevier Selects Inkling’s Digital Platform for Expert Consult, Student Consult
Medical education and reference content to be enhanced by new, intuitive digital platformPhiladelphia, PA, September 9, 2013
Elsevier, a world-leading provider of scientific, technical and medical information products and services, has selected Inkling, the creator of engaging, intuitive digital books for some of the world’s most respected publishers, to power the next generation of its popular Expert Consult and Student Consult medical reference and medical learning platforms.
All of Elsevier’s leading medical reference and learning content will be available through Inkling’s standard-setting reading and search experience. Both existing and new users will enjoy easy search, consistent structure, rich media, social and community features, and seamless electronic access from any device.
“This is a big step forward in the transition from print to digital publishing,” said Matt MacInnis, Founder and CEO of Inkling. “We’re migrating this valuable knowledge to a more flexible, more searchable format and, in doing so, making it possible to build whole new ways for people to find knowledge. Clearly, this is what tech-savvy physicians and medical students demand.”
As part of this agreement, Elsevier will bring more than 650 leading medical titles to Inkling and will use Inkling Habitat, the industry-leading cloud publishing platform, to build and manage this content so that it’s consistently structured, searchable, and easily updated. Expert Consult and Student Consult users will enjoy the Inkling features medical professionals and students around the globe have come to expect – truly interactive content that brings new meaning to illustrations, and allows readers’ annotations to travel across their devices and be shared with others.
Current Expert Consult and Student Consult users will be automatically upgraded to the new experience. New and returning customers can buy access to specific topics, individual chapters, and complete content sets directly on ExpertConsult.com and StudentConsult.com. In addition, customers who choose to buy physical books will also be granted access to the digital experience. No matter how customers choose to buy and use their medical content, the improved Expert Consult and Student Consult experience will enhance the way they find and learn from medical knowledge.
“Inkling’s technology platform, coupled with our extensive library of medical content, paves an exciting path forward for how we curate and distribute medical knowledge,” said Linda Belfus, Senior Vice President for Content, Elsevier. “We believe our customers will appreciate the interactivity, robust features and functionality, and convenience of the new Expert and Student Consult platforms.”
The content will also be available for purchase through Inkling.com alongside the existing catalog of Elsevier medical content. Inkling plans to roll out hundreds of additional digital titles, ranging from oncology to psychiatry, pediatrics to emergency medicine, and more, throughout 2013.
The new Expert Consult and Student Consult experiences will be available early in the first quarter of 2014.
# # #
Inkling is a pioneer in cloud publishing, reimagining the book and providing the technology to organize and distribute expert knowledge. Through Inkling, the world's leading publishers are building their best content into interactive and engaging experiences. Inkling is moving an entire industry forward, creating the infrastructure to transform words on paper into content in the cloud. Based in San Francisco, Inkling is backed by Sequoia Capital and partners with the world's leading publishers. For more information, visit www.inkling.com.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Director, Corporate Relations
+1 212 633 3164